However, Nlrp3−/− KC did not respond with upregulation of proinflammatory markers to ROS as expression of Tnf, iNos, Ccr8, Ccl22 and ActivinA remained at basal level after LCA treatment (Figure 7G). The gene discussed is NLRP3; the disease is Leber congenital amaurosis.